Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2015-04-13 Regulatory Filings
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated April 13, 2015, announcing the creation of a US subsidiary, Bone Therapeutics USA Inc., in Boston. It details strategic positioning for US clinical trials and quotes the CEO regarding the post-IPO strategy. This type of announcement, concerning corporate structure changes, strategic expansion, and executive commentary, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, or DIV). It is a general corporate announcement. Since it is not a formal regulatory filing like a 10-K or a specific event report (like an AGM presentation or an earnings call transcript), and it doesn't relate to management changes (MANG) or director dealings (DIRS), the most appropriate classification is the general regulatory/corporate announcement fallback category, RNS (Regulatory Filings), as it is a formal communication to the market about a significant corporate action.
2015-04-13 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic corporate action: the establishment of a US subsidiary (Bone Therapeutics USA Inc.) in Boston. This action is described as a key step following their recent IPO and is related to advancing their US clinical trial programs. This type of announcement, detailing corporate structure changes, strategic expansion, or fundraising/financing milestones, aligns best with the 'Capital/Financing Update' category, as establishing a subsidiary is a significant capital/structural move related to future financing/operations. While it is not explicitly about raising debt or equity, it is a fundamental change in capital structure/operational footprint following a major financing event (IPO). It is not an Earnings Release (ER), Interim Report (IR), or a formal regulatory filing like a 10-K. Given the context of strategic expansion and post-IPO activity, CAP (Capital/Financing Update) is the most appropriate fit among the provided options for a significant corporate structure announcement.
2015-04-13 English
20150219__PR_Denominator.pdf
Major Shareholding Notification Classification · 98% confidence The document explicitly states it 'discloses the information required under article 15 of the law of 2 May 2007 regarding the disclosure of important shareholdings in listed companies.' It then details changes to the total number of shares with voting rights (the denominator) following an option exercise. This content directly relates to reporting changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a press release format, the core subject matter is the mandatory disclosure of shareholding changes.
2015-02-19 English
20150219__PR_Denominator_FR.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions" (Information relative to the total number of voting rights and shares) and explicitly states it is published in accordance with Belgian law regarding the declaration of significant holdings. It details changes to the total number of voting rights (the denominator) after an over-allotment option exercise. This type of mandatory disclosure concerning the total number of shares and voting rights, often triggered by capital changes or regulatory requirements, fits best under the category of Major Shareholding Notification (MRQ) or a general Regulatory Filing (RNS). Since it specifically deals with the total share count used for calculating major holdings thresholds, MRQ is a strong candidate, but the content is a direct regulatory disclosure about the total share count itself, which is often a prerequisite for other filings. Given the options, this announcement of the total voting rights (the denominator) is a specific regulatory update related to share capital structure and ownership calculation basis. It is not an earnings release (ER), an interim report (IR), or a director's dealing (DIRS). It is a mandatory disclosure related to share capital structure changes impacting ownership reporting. This aligns closely with the scope of Major Shareholding Notification (MRQ) as it updates the base number used for tracking significant ownership, or potentially a general Regulatory Filing (RNS). Since it is a specific, mandatory disclosure about the total share count/voting rights, MRQ is the most precise fit among the options that deal with share ownership/capital structure changes, even though it's not a notification *of* a major shareholder crossing a threshold, but rather the underlying data for such calculations. However, looking closely at the definitions, MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document announces the total share count (the denominator) following an option exercise. This is a fundamental capital structure update. If it were a general regulatory announcement not fitting elsewhere, RNS would apply. Given the focus on the total number of shares/voting rights, it is a fundamental capital structure disclosure. Let's re-evaluate against the options. It is not a CAP (Financing Update) as the financing event (option exercise) has already occurred and this is the resulting disclosure. It is not SHA (Share Issue/Capital Change) as that usually announces the intent or completion of a primary issuance. Since it is a mandatory disclosure of the total voting rights denominator, which is a key regulatory metric, RNS (Regulatory Filings - fallback) is often used for these specific, non-standard disclosures, but MRQ relates to share ownership reporting. Given the context of Belgian law disclosure on voting rights, this is a specific regulatory filing. I will classify it as RNS as it is a general regulatory disclosure about share structure, which doesn't perfectly match the specific definitions of SHA or MRQ, making RNS the safest fit for a mandatory, non-financial report regulatory update.
2015-02-19 French
20150219__PR_Denominator_NL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Informatie over het totale aantal stemrechten en effecten" (Information on the total number of voting rights and securities) and explicitly states it is providing information according to Article 15 of the Belgian law regarding the disclosure of major shareholdings. It details the 'Noemer' (Denominator) including the total number of voting rights (6,849,654) and total number of voting rights securities. This content directly relates to changes in significant share ownership thresholds, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is a press release format, the core regulatory content is about shareholding disclosure, not a general regulatory announcement (RNS) or a dividend notice (DIV).
2015-02-19 Dutch
20150217__PR_TranspDecl_EN.pdf
Major Shareholding Notification Classification · 99% confidence The document explicitly states that the company 'announces it has received notifications of shareholding from various parties' and details the exact share percentages held by specific entities (S.R.I.W., Mr J. Reymann, SFPI SA, Theodorus II SA), referencing the Belgian Law concerning 'disclosure of major holdings'. This content directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2015-02-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.